EMPHATEN Trademark

Trademark Overview

On Thursday, February 17, 2005, a trademark application was filed for EMPHATEN with the United States Patent and Trademark Office. The USPTO has given the EMPHATEN trademark a serial number of 76631061. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 6, 2014. This trademark is owned by Solvay Pharmaceuticals Marketing & Licensing AG.. The EMPHATEN trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICALS TO TREAT DISEASES AND DISORDERS OF THE CARDIOVASCULAR SYSTEM
emphaten

General Information

Serial Number76631061
Word MarkEMPHATEN
Filing DateThursday, February 17, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 6, 2014
Registration Number3322090
Registration DateTuesday, October 30, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2007

Trademark Statements

Goods and ServicesPHARMACEUTICALS TO TREAT DISEASES AND DISORDERS OF THE CARDIOVASCULAR SYSTEM

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 6, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameABBOTT PRODUCTS OPERATIONS AG
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressALLSCHWIL 4123
CH
Party NameSolvay Pharmaceuticals Marketing & Licensing AG.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAllschwil
CH
Party NameSolvay Pharmaceuticals Marketing & Licensing AG.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAllschwil
CH
Party NameSolvay Pharmaceuticals Marketing & Licensing AG.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAllschwil
CH

Trademark Events

Event DateEvent Description
Friday, June 6, 2014CANCELLED SEC. 8 (6-YR)
Wednesday, June 2, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 30, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, August 14, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 25, 2007NOTICE OF PUBLICATION
Saturday, July 7, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, July 7, 2007ASSIGNED TO LIE
Tuesday, June 5, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 5, 2007PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, May 10, 20071(B) BASIS DELETED; NEW BASIS REQUESTED
Monday, April 16, 2007NOTICE OF ALLOWANCE CANCELLED
Wednesday, May 2, 2007PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, April 26, 2007ASSIGNED TO PETITION STAFF
Monday, April 16, 2007PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Monday, April 16, 2007PAPER RECEIVED
Thursday, December 7, 2006EXTENSION 1 GRANTED
Tuesday, October 17, 2006EXTENSION 1 FILED
Tuesday, October 17, 2006PAPER RECEIVED
Tuesday, April 18, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 24, 2006PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2006NOTICE OF PUBLICATION
Friday, December 9, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 9, 2005ASSIGNED TO LIE
Friday, December 2, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 1, 2005AMENDMENT FROM APPLICANT ENTERED
Tuesday, November 15, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 15, 2005PAPER RECEIVED
Thursday, September 15, 2005EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED
Thursday, September 15, 2005EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, September 14, 2005ASSIGNED TO EXAMINER
Tuesday, March 1, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

emphaten cardiovascular system disorders diseases treat pharmaceuticals